Salmeterol: A study by prescription-event monitoring in a UK cohort of 15,407 patients

Journal of Clinical Epidemiology

Volumn 49, Issue 2, 1996, Pages 247-250

  Mann, Ronald D ^a   Kubota, Kiyoshi ^a   Pearce, Gillian ^a   Wilton, Lynda ^a  

^a DRUG SAFETY RESEARCH UNIT   (United Kingdom)

Author keywords

Asthma; Pharmacovigilance pharmacoepidemiology; Prescription event monitoring; Salmeterol

Indexed keywords

SALMETEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CHILD; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DEATH CERTIFICATE; DRUG MONITORING; DRUG SAFETY; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HEADACHE; HEART PALPITATION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PHARMACOEPIDEMIOLOGY; PREGNANCY; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; TREATMENT OUTCOME; TREMOR; UNITED KINGDOM;

EID: 0029863121     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-4356(95)00555-2     Document Type: Article

References (16)

1. Mann RD. Epidemiologic study systems: Prescription-Event Monitoring in the UK. Southampton Med J 1994; 10: 12-17.
2. Inman WHW, Kubota K, Wilton LV, Pearce GL. PEM Report No. 1. Nicardipine. Pharmacoepidemiol Drug Safety 1993; 2: 259-285.
3. Inman WHW, Clarke J, Wilton LV, Pearce GL, Veldhuis G. PEM Report No. 2. Terodiline. Pharmacoepidemiol Drug Safety 1993; 2: 287-319.
4. Inman WHW, Kubota K, Pearce GL, Wilton LV. PEM Report No. 3. Fluconazole. Pharmacoepidemiol Drug Safety 1993; 2: 321-340.
5. Inman WHW, Kubota K, Pearce GL, Wilton LV. PEM Report No. 4. Ciprofloxacin. Pharmacoepidemiol Drug Safety 1993; 2: 341-364.
6. Inman WHW, Kubota K, Pearce GL, Wilton LV. PEM Report No. 5. Fluoxetine. Pharmacoepidemiol Drug Safety 1993; 2: 365-391.
7. Inman WHW, Kubota K, Pearce GL, Wilton LV. PEM Report No. 6. Paroxetine. Pharmacoepidemiol Drug Safety 1993; 2: 393-422.
8. Inman WHW, Kubota K, Pearce GL, Wilton LV. PEM Report No. 7. Itraconazole. Pharmacoepidemiol Drug Safety 1993; 2: 423-443.
9. Inman WHW, Kubota K, Pearce GL, Wilton LV. PEM Report No. 8. Cisapride. Pharmacoepidemiol Drug Safety 1993; 2: 445-471.
10. Wilton LV, Inman WHW, Kubota K, Pearce GL, Skipp M. PEM Report No. 9. Omeprazole. Pharmacoepidemiol Drug Safety 1993; 2: 473-498.
11. Inman WHW, Kubota K, Pearce GL, Wilton LV. PEM Report No. 10. Zopiclone. Pharmacoepidemiol Drug Safety 1993; 2: 499-521.
12. Inman WHW, Rawson NSB, Wilton LV, Pearce GL, Speirs CJ. Post-marketing surveillance of enalapril. I: Results of prescription-event monitoring. Br Med J. 1988; 297: 826-829.
13. Rawson NSB. An acute adverse drug reaction alerting scheme using the Saskatchewan health datafiles. Drug Invest 1993; 6(5): 245-256.
14. Kubota K, Kubota N, Pearce G, Prescott P, Mann RD. Signalling drug-induced rash with 36 drugs recently marketed in the United Kingdom and studied by Prescription-Event Monitoring. Int J Clin Pharmacol Ther 1995; 33(4): 219-225.
15. Castle WM, Fuller RW, Hal JR, Palmer JBD. Serevent nationwide surveillance study: Comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment. Br Med J 1993; 306: 1034-1037.
16. Bunney R. Study too small to detect increase in deaths (letter). Br Med J 1993; 306: 1610.